837 Ribosomal protein S16
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Mixed metal/non-metal compounds | 2 | 0.2 | 12× | not tested | |
| Homogeneous metal compounds | 8 | 3.9 | 2.07× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
No DrugBank compounds are annotated on this group's domains.
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 322 |
| FES | FE2/S2 (INORGANIC) CLUSTER | 54 |
| ZNmetal | ZINC ION | 28 |
| Kmetal | POTASSIUM ION | 8 |
| OHX | osmium (III) hexammine | 8 |
| FS2 | FE-S-O HYBRID CLUSTER | 3 |
| NMY | NEOMYCIN | 2 |
| UNX | UNKNOWN ATOM OR ION | 2 |
| PAR | PAROMOMYCIN | 1 |